Long-Chain Omega-3 Fatty Acids and Psychotic Disorders

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/978-1-62703-215-5_9
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Polyunsaturated fatty acids in emerging psychosis.

  2012cited by this paper
• Eicosapentaenoic Acid Interventions in Schizophrenia: Meta-Analysis of Randomized, Placebo-Controlled Studies

  2012cited by this paper
• RACK1, A multifaceted scaffolding protein: Structure and function

  2011cited by this paper
• White matter alterations related to P300 abnormalities in individuals at high risk for psychosis: an MRI-EEG study.

  2011cited by this paper
• A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis.

  2011cited by this paper
• Bimodal distribution of polyunsaturated fatty acids in schizophrenia suggests two endophenotypes of the disorder.

  2011cited by this paper
• Phospholipase A2 activity in first episode schizophrenia: Associations with symptom severity and outcome at week 12

  2011cited by this paper
• Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia.

  2011cited by this paper
• Maternal serum docosahexaenoic acid and schizophrenia spectrum disorders in adult offspring.

  2011cited by this paper
• Membrane fatty acid levels as a predictor of treatment response in chronic schizophrenia.

  2011cited by this paper
• Omega-3 fatty acids, inflammation and angiogenesis: basic mechanisms behind the cardioprotective effects of fish and fish oils.

  2010cited by this paper
• Polyunsaturated fatty acids deficits are associated with psychotic state and negative symptoms in patients with schizophrenia.

  2010cited by this paper
• Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial.

  2010cited by this paper
• Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk

  2010cited by this paper
• Polyunsaturated fatty acids in the modulation of T-cell signalling.

  2010cited by this paper
• Do FADS genotypes enhance our knowledge about fatty acid related phenotypes?

  2010cited by this paper
• Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.

  2010cited by this paper
• Phospholipid profile in the postmortem hippocampus of patients with schizophrenia and bipolar disorder: no changes in docosahexaenoic acid species.

  2010cited by this paper
• Clinical Staging: A Heuristic and Practical Strategy for New Research and Better Health and Social Outcomes for Psychotic and Related Mood Disorders

  2010cited by this paper
• EEG spectral power and negative symptoms in at-risk individuals predict transition to psychosis.

  2010cited by this paper
• Neuroprotective effects of ethyl-eicosapentaenoic acid in first episode psychosis: a longitudinal T2 relaxometry pilot study.

  2010cited by this paper
• Phospholipase A2 activity is associated with structural brain changes in schizophrenia

  2010cited by this paper
• Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness.

  2010cited by this paper
• Changes in erythrocyte membrane fatty acids during a clinical trial of eicosapentaenoic acid (EPA) supplementation in schizophrenia

  2009cited by this paper
• Evidence-Based Medicine and Electrophysiology in Schizophrenia

  2009cited by this paper
• Resting state electroencephalographic correlates with red cell long-chain fatty acids, memory performance and age in adolescent boys with attention deficit hyperactivity disorder.

  2009cited by this paper
• Genome-Wide Association Study of Plasma Polyunsaturated Fatty Acids in the InCHIANTI Study

  2009cited by this paper
• The status of spectral EEG abnormality as a diagnostic test for schizophrenia.

  2008cited by this paper
• Safety of the omega-3 fatty acid, eicosapentaenoic acid (EPA) in psychiatric patients: results from a randomized, placebo-controlled trial.

  2008cited by this paper
• Role of n-3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease.

  2008cited by this paper
• Ethyl-Eicosapentaenoic Acid in First-Episode Psychosis. A 1H-MRS Study

  2008cited by this paper
• Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder.

  2008cited by this paper
• Evidence for an association between genetic variants of the fatty acid desaturase 1 fatty acid desaturase 2 (FADS1 FADS2) gene cluster and the fatty acid composition of erythrocyte membranes

  2008cited by this paper
• Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): an observational cohort study.

  2007cited by this paper
• Omega-3 fatty acids and sudden cardiac death in schizophrenia: if not a friend, at least a great colleague.

  2007cited by this paper
• Expert opinion: omega-3 fatty acids and bleeding-cause for concern?

  2007cited by this paper
• Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications.

  2007cited by this paper
• Three-year follow-up of a randomized controlled trial of cognitive therapy for the prevention of psychosis in people at ultrahigh risk.

  2007cited by this paper
• The impact of ω-3 fatty acids, vitamins E and C supplementation on treatment outcome and side effects in schizophrenia patients treated with haloperidol: An open-label pilot study

  2007cited by this paper
• Neuroprotection in emerging psychotic disorders

  2007cited by this paper
• Depressed mood and n-3 polyunsaturated fatty acid intake from fish: non-linear or confounded association?

  2007cited by this paper
• The n-3 polyunsaturated fatty acid/dopamine hypothesis of schizophrenia.

  2007cited by this paper
• North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research.

  2007cited by this paper
• Depressed mood and dietary fish intake: direct relationship or indirect relationship as a result of diet and lifestyle?

  2007cited by this paper
• Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder.

  2007cited by this paper
• Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial.

  2007cited by this paper
• The Basel early‐detection‐of‐psychosis (FEPSY)‐study – design and preliminary results

  2007cited by this paper
• Role of omega-3 fatty acids in brain development and function: potential implications for the pathogenesis and prevention of psychopathology.

  2006cited by this paper
• Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids.

  2006cited by this paper
• The role of phospholipases A2 in schizophrenia

  2006cited by this paper
• Nutrition in Brain Development and Aging: Role of Essential Fatty Acids

  2006cited by this paper
• Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis.

  2006cited by this paper
• Polyunsaturated fatty acid supplementation for schizophrenia.

  2006cited by this paper
• The effects of eicosapentaenoic acid in tardive dyskinesia: a randomized, placebo-controlled trial.

  2006cited by this paper
• Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the opus trial. A randomized clinical trial of integrated treatment and standard treatment

  2006cited by this paper
• Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry.

  2006cited by this paper
• Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review.

  2006cited by this paper
• Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity.

  2006cited by this paper
• n-3 fatty acids and cardiovascular disease.

  2006cited by this paper
• Effect of Omega-3 Fatty Acids on the Lipid Profile of Patients Taking Clozapine

  2006cited by this paper
• Correlates of regular fish consumption in French elderly community dwellers: data from the Three-City study

  2005cited by this paper
• Effects of omega-3 fatty acids on mental health.

  2005cited by this paper
• Cognitive and physiological effects of Omega‐3 polyunsaturated fatty acid supplementation in healthy subjects

  2005cited by this paper
• Effects of eicosapentaenoic acids on oxidative stress and plasma fatty acid composition in patients with lupus nephritis.

  2005cited by this paper
• Increased calcium-independent phospholipase A2 activity in first but not in multiepisode chronic schizophrenia.

  2005cited by this paper
• Lipid signaling in neural plasticity, brain repair, and neuroprotection

  2005cited by this paper
• Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

  2005cited by this paper
• Co-culture of neurones with glutathione deficient astrocytes leads to increased neuronal susceptibility to nitric oxide and increased glutamate-cysteine ligase activity.

  2005cited by this paper
• Effect of ω-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo-controlled, double-blind trial

  2005cited by this paper
• Docosahexaenoic acid promotes neurite growth in hippocampal neurons

  2004cited by this paper
• International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: An ecological analysis

  2004cited by this paper
• Association of fish and fish liver oil intake in pregnancy with infant size at birth among women of normal weight before pregnancy in a fishing community.

  2004cited by this paper
• Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline.

  2004cited by this paper
• Omega-3 status and cerebrospinal fluid corticotrophin releasing hormone in perpetrators of domestic violence.

  2004cited by this paper
• Cognitive therapy for the prevention of psychosis in people at ultra-high risk

  2004cited by this paper
• Daily omega-3 fatty acid intake and depression in Japanese patients with newly diagnosed lung cancer

  2004cited by this paper
• Polyunsaturated fatty acid levels in red cell membranes of unmedicated schizophrenic patients

  2004cited by this paper
• Omega-3 Fatty Acid Treatment and T2 Whole Brain Relaxation Times in Bipolar Disorder

  2004cited by this paper
• Membrane phospholipids and cytokine interaction in schizophrenia.

  2004cited by this paper
• Fish consumption and depression: the Northern Finland 1966 birth cohort study.

  2004cited by this paper
• Dietary intake of n-3, n-6 fatty acids and fish: Relationship with hostility in young adults—the CARDIA study

  2004cited by this paper
• Dietary sugar and polyunsaturated fatty acid consumption as predictors of severity of schizophrenia symptoms.

  2004cited by this paper
• The end of the party

  2004cited by this paper
• The investigation of cytosolic phospholipase A2 using ELISA.

  2004cited by this paper
• Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases.

  2004cited by this paper
• Nutrition and schizophrenia: beyond omega-3 fatty acids.

  2004cited by this paper
• Cross-national comparisons of seafood consumption and rates of bipolar disorders.

  2003cited by this paper
• Essential Fatty Acids and the Brain

  2003cited by this paper
• Can Breast-Feeding Protect against Schizophrenia?

  2003cited by this paper
• Early Detection and Intervention in the Initial Prodromal Phase of Schizophrenia

  2003cited by this paper
• Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients.

  2003cited by this paper
• Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment.

  2003cited by this paper
• Differential effect of nitric oxide on glutathione metabolism and mitochondrial function in astrocytes and neurones: implications for neuroprotection/neurodegeneration?

  2003cited by this paper
• Effects of docosapentaenoic acid on neuronal apoptosis

  2003cited by this paper
• Supplementation with a combination of ω-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia

  2003cited by this paper
• Prefrontal membrane phospholipid metabolism of child and adolescent offspring at risk for schizophrenia or schizoaffective disorder: an in vivo 31P MRS study

  2003cited by this paper
• Effects of supplementation with fish oil-derived n-3 fatty acids and gamma-linolenic acid on circulating plasma lipids and fatty acid profiles in women.

  2003cited by this paper
• Fluorometric Assays of Phospholipase A2 Activity with Three Different Substrates in Biological Samples of Patients with Schizophrenia

  2003cited by this paper
• Increased phospholipase A2 activity in schizophrenia with absent response to niacin.

  2003cited by this paper
• Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group.

  2003cited by this paper

• The impact of fatty acids biosynthesis on the risk of cardiovascular diseases in Europeans and East Asians: a Mendelian randomization study

  2022cites this paper
• Urinary biopyrrins and free immunoglobin light chains are biomarker candidates for screening at‐risk mental state in adolescents

  2021cites this paper
• Role of Specialized Pro-Resolving Mediators in Neuropathic Pain

  2021cites this paper
• Subtype specific responses in hKv7.4 and hKv7.5 channels to polyunsaturated fatty acids

  2021cites this paper
• Attrition rates in trials for adolescents and young adults at clinical high‐risk for psychosis: A systematic review and meta‐analysis

  2020cites this paper
• Polyunsaturated Fatty Acids in Newborn Bloodspots: Associations With Autism Spectrum Disorder and Correlation With Maternal Serum Levels

  2020cites this paper
• Interaction between iron and omega-3 fatty acids metabolisms: where is the cross-link?

  2020cites this paper
• Maternal fatty acid and inflammatory status during pregnancy are related to infant heart rate and heart rate variability

  2017cites this paper